Ledger.Open graph →
SEC Form D · Amendment · filed August 2, 2017

Arbor Biotechnologies, Inc

Offering
$15.6M
Sold
$15.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Campbell C. Lewis · Dallas, TXExecMichael E. Olshan · Dallas, TXExecCraig Brazeau · Plainfield, ILDirectorP. R. Morrow, Ii · Dallas, TXDirectorShane Albers · Scottsdale, AZDirectorWilliam Abraham · New Brighton, MNDirectorMichael Demane · New Brighton, MNDirectorTony Borowicz · New Brighton, MNExecAmy Boyle · New York, NYExecThomas Feldstein · New York, NYDirectorThomas Shapiro · New York, NYDirectorRobert Vahradian · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗